Immunome IMNM Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $5.49M+85.5% | $2.96M+10.4% | $2.68M-13.0% | $3.08M+2.8% | $3M+10.1% | ||
| $0— | $0— | $0-100% | $4.02M+37.2% | $2.93M+6.9% | ||
| $46.38M-8.6% | $50.77M+3.2% | $49.19M+21.6% | $40.45M+9.7% | $36.87M-23.0% | ||
| $12.95M+7.1% | $12.09M+10.5% | $10.95M+9.0% | $10.04M-6.1% | $10.69M+2.3% | ||
| $59.33M-18.6% | $72.86M+21.2% | $60.14M+19.1% | $50.49M+6.2% | $47.56M-44.5% | ||
| -$59.33M+18.6% | -$72.86M-21.2% | -$60.14M-29.4% | -$46.48M-4.1% | -$44.64M+46.2% | ||
| -$53.84M+23.0% | -$69.9M-21.7% | -$57.46M-32.4% | -$43.4M-4.2% | -$41.64M+48.1% | ||
| -$0.48+36.0% | -$0.75-15.4% | -$0.65-30.0% | -$0.50+3.8% | -$0.52+59.4% | ||
| -$58.73M+18.7% | -$72.23M-21.3% | -$59.55M-29.9% | -$45.84M-4.1% | -$44.03M+46.6% | ||
| -$59.33M+18.6% | -$72.86M-21.2% | -$60.14M-29.4% | -$46.48M-4.1% | -$44.64M+46.2% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where does Immunome's income statement data come from?
- Every line is extracted from Immunome's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.